Veracyte, Inc.
VCYT
Cena:
Valuace
30
Růst
100
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 13.2 mil | 16.76% | 0.00% | 0.01% | 2024-09-30 |
| VANGUARD GROUP INC | 8.5 mil | 10.80% | 0.00% | 0.01% | 2013-12-31 |
| BLACKROCK INC. | 7.8 mil | 10.42% | 0.00% | 0.00% | 2016-03-31 |
| FMR LLC | 7.8 mil | 9.88% | 0.00% | 0.01% | 2019-12-31 |
| BLACKROCK FUNDING, INC. /DE | 7.5 mil | 9.77% | 0.00% | 0.01% | 2024-09-30 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 5.5 mil | 6.99% | -0.11% | 0.28% | 2019-09-30 |
| STATE STREET CORP | 5.0 mil | 6.42% | 0.00% | 0.01% | 2013-12-31 |
| 3.5 mil | 4.49% | 0.00% | 0.00% | 2026-03-31 | |
| ARK INVESTMENT MANAGEMENT LLC | 3.1 mil | 3.89% | -0.32% | 0.76% | 2016-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 2.9 mil | 3.67% | -0.01% | 0.02% | 2020-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.6 mil | 3.26% | 0.00% | 0.02% | 2019-09-30 |
| FIRST TRUST ADVISORS LP | 2.1 mil | 2.69% | 0.01% | 0.05% | 2019-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.0 mil | 2.49% | 0.00% | 0.00% | 2014-03-31 |
| BANK OF AMERICA CORP /DE/ | 1.4 mil | 1.84% | 0.00% | 0.00% | 2014-09-30 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.4 mil | 1.83% | -0.01% | 0.41% | 2019-12-31 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.4 mil | 1.80% | -0.04% | 0.15% | 2025-12-31 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.4 mil | 1.75% | -0.27% | 1.18% | 2020-03-31 |
| GOLDMAN SACHS GROUP INC | 1.3 mil | 1.62% | 0.00% | 0.00% | 2015-03-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.2 mil | 1.55% | 0.00% | 0.01% | 2019-06-30 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.1 mil | 1.34% | -0.01% | 0.02% | 2019-03-31 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.0 mil | 1.33% | -0.14% | 0.48% | 2018-09-30 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 989.69 tis | 1.26% | 0.01% | 0.11% | 2025-09-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 983.79 tis | 1.26% | 0.00% | 0.03% | 2022-09-30 |
| IRON TRIANGLE PARTNERS LP | 980.39 tis | 1.25% | 2.35% | 4.72% | 2025-09-30 |
| MARSHALL WACE, LLP | 956.58 tis | 1.24% | 0.04% | 0.05% | 2024-09-30 |
| NORTHERN TRUST CORP | 929.50 tis | 1.18% | 0.00% | 0.00% | 2013-12-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 923.57 tis | 1.18% | 0.00% | 0.00% | 2015-06-30 |
| SQUAREPOINT OPS LLC | 897.39 tis | 1.15% | 0.02% | 0.03% | 2022-09-30 |
| LEGAL & GENERAL GROUP PLC | 897.17 tis | 1.14% | 0.00% | 0.01% | 2016-12-31 |
| OBERWEIS ASSET MANAGEMENT INC/ | 839.83 tis | 1.07% | -0.32% | 0.80% | 2022-12-31 |
| ASSENAGON ASSET MANAGEMENT S.A. | 830.10 tis | 1.06% | 0.01% | 0.03% | 2021-12-31 |
| ALYESKA INVESTMENT GROUP, L.P. | 808.57 tis | 1.03% | 0.00% | 0.07% | 2025-09-30 |
| MORGAN STANLEY | 797.80 tis | 1.02% | 0.00% | 0.00% | 2013-12-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 734.45 tis | 0.95% | 0.03% | 0.15% | 2022-12-31 |
| FISHER ASSET MANAGEMENT, LLC | 736.27 tis | 0.94% | 0.00% | 0.01% | 2021-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 726.00 tis | 0.92% | -0.11% | 0.28% | 2025-06-30 |
| CANDRIAM S.C.A. | 670.94 tis | 0.90% | -0.01% | 0.09% | 2022-03-31 |
| FIERA CAPITAL CORP | 625.54 tis | 0.84% | 0.00% | 0.04% | 2018-12-31 |
| BAMCO INC /NY/ | 655.52 tis | 0.83% | -0.01% | 0.06% | 2019-06-30 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 631.71 tis | 0.80% | 0.18% | 0.18% | 2025-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 610.40 tis | 0.78% | -0.02% | 0.02% | 2023-06-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 608.85 tis | 0.78% | 0.00% | 0.00% | 2018-12-31 |
| SEGALL BRYANT & HAMILL, LLC | 591.49 tis | 0.75% | -0.10% | 0.24% | 2021-03-31 |
| FRED ALGER MANAGEMENT, LLC | 579.46 tis | 0.74% | -0.02% | 0.08% | 2025-09-30 |
| ROYAL BANK OF CANADA | 573.10 tis | 0.73% | 0.00% | 0.00% | 2014-03-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 570.72 tis | 0.73% | -0.01% | 0.38% | 2014-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 548.17 tis | 0.70% | 0.00% | 0.00% | 2026-03-31 |
| JPMORGAN CHASE & CO | 496.22 tis | 0.63% | 0.00% | 0.00% | 2016-09-30 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 465.99 tis | 0.62% | 0.01% | 0.02% | 2019-09-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 483.90 tis | 0.62% | 0.00% | 0.02% | 2025-12-31 |
| CITADEL ADVISORS LLC | 477.85 tis | 0.61% | 0.00% | 0.00% | 2016-12-31 |
| NEXT CENTURY GROWTH INVESTORS LLC | 476.22 tis | 0.61% | -0.46% | 1.26% | 2023-12-31 |
| PRINCIPAL FINANCIAL GROUP INC | 476.69 tis | 0.61% | 0.00% | 0.01% | 2019-06-30 |
| MACQUARIE GROUP LTD | 470.35 tis | 0.60% | 0.00% | 0.02% | 2024-09-30 |
| INVESCO LTD. | 436.59 tis | 0.56% | 0.00% | 0.00% | 2017-06-30 |
| MAN GROUP PLC | 415.77 tis | 0.54% | 0.00% | 0.04% | 2023-06-30 |
| NEW YORK STATE COMMON RETIREMENT FUND | 421.63 tis | 0.54% | -0.01% | 0.02% | 2015-06-30 |
| SEI INVESTMENTS CO | 420.09 tis | 0.53% | 0.00% | 0.01% | 2018-09-30 |
| BANK OF NEW YORK MELLON CORP | 413.42 tis | 0.53% | 0.00% | 0.00% | 2014-03-31 |
| LOOMIS SAYLES & CO L P | 409.47 tis | 0.52% | -0.01% | 0.01% | 2024-12-31 |
| RAYMOND JAMES FINANCIAL INC | 370.26 tis | 0.47% | 0.00% | 0.00% | 2024-12-31 |
| BNP PARIBAS ARBITRAGE, SNC | 362.84 tis | 0.46% | 0.00% | 0.01% | 2014-09-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 357.56 tis | 0.45% | 1.00% | 2.09% | 2021-03-31 |
| JUPITER ASSET MANAGEMENT LTD | 355.60 tis | 0.45% | -0.06% | 0.06% | 2025-09-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 343.97 tis | 0.44% | 0.00% | 0.00% | 2019-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 325.52 tis | 0.42% | -0.01% | 0.01% | 2024-09-30 |
| AEGON ASSET MANAGEMENT UK PLC | 326.63 tis | 0.42% | -0.11% | 0.14% | 2023-12-31 |
| RAFFERTY ASSET MANAGEMENT, LLC | 308.56 tis | 0.41% | 0.01% | 0.03% | 2019-03-31 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 319.91 tis | 0.41% | 0.40% | 0.42% | 2025-06-30 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 311.98 tis | 0.41% | 0.12% | 0.42% | 2019-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 298.96 tis | 0.38% | 0.01% | 0.01% | 2025-06-30 |
| GRANITE INVESTMENT PARTNERS, LLC | 298.59 tis | 0.38% | -0.28% | 0.59% | 2020-03-31 |
| JANE STREET GROUP, LLC | 296.26 tis | 0.38% | 0.00% | 0.00% | 2020-06-30 |
| CITIGROUP INC | 273.41 tis | 0.38% | 0.00% | 0.00% | 2013-12-31 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 282.84 tis | 0.36% | -0.01% | 0.03% | 2025-09-30 |
| CHAMPLAIN INVESTMENT PARTNERS, LLC | 281.92 tis | 0.36% | -0.18% | 0.12% | 2025-09-30 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 279.19 tis | 0.36% | 0.00% | 0.03% | 2023-03-31 |
| CASDIN CAPITAL, LLC | 276.31 tis | 0.35% | -0.05% | 0.67% | 2024-03-31 |
| NORDEA INVESTMENT MANAGEMENT AB | 272.60 tis | 0.35% | 0.00% | 0.01% | 2023-09-30 |
| DUQUESNE FAMILY OFFICE LLC | 259.94 tis | 0.35% | 0.06% | 0.19% | 2024-03-31 |
| PICTON MAHONEY ASSET MANAGEMENT | 267.21 tis | 0.34% | -0.06% | 0.07% | 2024-09-30 |
| ALGERT GLOBAL LLC | 261.82 tis | 0.34% | 0.06% | 0.24% | 2022-06-30 |
| JENNISON ASSOCIATES LLC | 265.87 tis | 0.34% | -0.02% | 0.00% | 2023-09-30 |
| UBS GROUP AG | 264.56 tis | 0.34% | 0.00% | 0.00% | 2014-12-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 255.44 tis | 0.33% | 0.05% | 0.05% | 2018-09-30 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 243.88 tis | 0.33% | -0.07% | 0.92% | 2021-12-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 248.58 tis | 0.32% | 0.02% | 0.03% | 2020-12-31 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 239.57 tis | 0.32% | 0.01% | 0.01% | 2024-06-30 |
| SUMMIT CREEK ADVISORS LLC | 248.13 tis | 0.32% | 1.24% | 1.24% | 2025-09-30 |
| MILLENNIUM MANAGEMENT LLC | 240.21 tis | 0.31% | 0.00% | 0.00% | 2013-12-31 |
| BARCLAYS PLC | 242.35 tis | 0.31% | 0.00% | 0.00% | 2016-09-30 |
| NUVEEN, LLC | 238.44 tis | 0.30% | 0.00% | 0.00% | 2025-03-31 |
| LORD, ABBETT & CO. LLC | 234.69 tis | 0.30% | -0.02% | 0.02% | 2024-09-30 |
| AQR CAPITAL MANAGEMENT LLC | 230.30 tis | 0.30% | 0.00% | 0.01% | 2022-12-31 |
| NORGES BANK | 225.60 tis | 0.29% | 0.00% | 0.00% | 2024-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 209.48 tis | 0.28% | -0.08% | 0.61% | 2021-09-30 |
| FRANKLIN RESOURCES INC | 216.66 tis | 0.28% | 0.00% | 0.00% | 2023-06-30 |
| AMI ASSET MANAGEMENT CORP | 203.72 tis | 0.27% | -0.06% | 0.23% | 2023-03-31 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 199.40 tis | 0.27% | 0.10% | 0.10% | 2024-06-30 |
| CASTLEARK MANAGEMENT LLC | 178.21 tis | 0.24% | 0.07% | 0.22% | 2022-12-31 |
| PUTNAM INVESTMENTS LLC | 159.79 tis | 0.22% | 0.00% | 0.01% | 2019-09-30 |
| EAGLE ASSET MANAGEMENT INC | 155.85 tis | 0.21% | 0.00% | 0.02% | 2021-06-30 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 148.75 tis | 0.20% | -0.06% | 0.13% | 2023-12-31 |
| SWISS NATIONAL BANK | 146.20 tis | 0.20% | 0.00% | 0.00% | 2019-06-30 |
| GREAT LAKES ADVISORS, LLC | 139.69 tis | 0.19% | 0.00% | 0.03% | 2024-03-31 |
| EXCHANGE TRADED CONCEPTS, LLC | 132.30 tis | 0.18% | -0.01% | 0.07% | 2019-12-31 |
| QRG CAPITAL MANAGEMENT, INC. | 129.42 tis | 0.17% | 0.00% | 0.03% | 2023-09-30 |
| RHUMBLINE ADVISERS | 128.77 tis | 0.17% | 0.00% | 0.00% | 2015-06-30 |
| ENVESTNET ASSET MANAGEMENT INC | 120.01 tis | 0.16% | 0.00% | 0.00% | 2019-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Leite John | officer: Global Chief Commercial Off | S-Sale | 13975 | 50.07 | 4.6 2026 | 132305 |
| Leite John | officer: Global Chief Commercial Off | F-InKind | 4059 | 47.80 | 4.6 2026 | 146280 |
| Stapley Marc | director, officer: Chief Executive Officer | M-Exempt | 138051 | 36.60 | 4.6 2026 | 0 |
| Stapley Marc | director, officer: Chief Executive Officer | S-Sale | 138051 | 50.12 | 4.6 2026 | 440494 |
| Stapley Marc | director, officer: Chief Executive Officer | F-InKind | 9012 | 47.80 | 4.6 2026 | 440494 |
| Stapley Marc | director, officer: Chief Executive Officer | M-Exempt | 138051 | 36.60 | 4.6 2026 | 578545 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | F-InKind | 3730 | 47.80 | 4.6 2026 | 149797 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 1961 | 50.09 | 4.6 2026 | 173280 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 1600 | 49.28 | 4.6 2026 | 175241 |
| Chambers Rebecca | officer: Chief Financial Officer | F-InKind | 3693 | 47.80 | 4.6 2026 | 176841 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | F-InKind | 1361 | 47.80 | 4.6 2026 | 44073 |
| McGuire Annie | officer: EVP, General Counsel | S-Sale | 1776 | 50.12 | 4.6 2026 | 137240 |
| McGuire Annie | officer: EVP, General Counsel | S-Sale | 1400 | 49.31 | 4.6 2026 | 139016 |
| McGuire Annie | officer: EVP, General Counsel | F-InKind | 3292 | 47.80 | 4.6 2026 | 140416 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | M-Exempt | 24000 | 24.80 | 27.5 2026 | 0 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | S-Sale | 24000 | 45.40 | 27.5 2026 | 45434 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | M-Exempt | 24000 | 24.80 | 27.5 2026 | 69434 |
| EPSTEIN ROBERT S | director | S-Sale | 10000 | 44.01 | 22.5 2026 | 52446 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 5102 | 40.00 | 8.5 2026 | 143708 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 5102 | 38.05 | 8.5 2026 | 148810 |
| Haas Kevin Richard | officer: Chief Dev and Tech Officer | A-Award | 44221 | 0.00 | 14.4 2026 | 44221 |
| Haas Kevin Richard | officer | 0 | 0.00 | 25.3 2026 | 0 | |
| Chambers Rebecca | officer: Chief Financial Officer | A-Award | 36181 | 0.00 | 10.3 2026 | 167377 |
| Chambers Rebecca | officer: Chief Financial Officer | A-Award | 13157 | 0.00 | 10.3 2026 | 180534 |
| Stapley Marc | director, officer: Chief Executive Officer | A-Award | 92099 | 0.00 | 10.3 2026 | 449653 |
| Leite John | officer: Chief Commercial Officer-CLIA | A-Award | 36181 | 0.00 | 10.3 2026 | 143761 |
| Leite John | officer: Chief Commercial Officer-CLIA | A-Award | 6578 | 0.00 | 10.3 2026 | 150339 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | A-Award | 29603 | 0.00 | 10.3 2026 | 146949 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | A-Award | 6578 | 0.00 | 10.3 2026 | 153527 |
| McGuire Annie | officer: SVP, General Counsel | A-Award | 32892 | 0.00 | 10.3 2026 | 127598 |
| McGuire Annie | officer: SVP, General Counsel | A-Award | 26314 | 0.00 | 10.3 2026 | 153912 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | A-Award | 10525 | 0.00 | 10.3 2026 | 45434 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 1664 | 36.34 | 6.3 2026 | 94706 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 4994 | 35.29 | 6.3 2026 | 96370 |
| Leite John | officer: Chief Commercial Officer-CLIA | S-Sale | 5260 | 35.19 | 6.3 2026 | 107580 |
| Stapley Marc | director, officer: Chief Executive Officer | S-Sale | 26279 | 36.28 | 6.3 2026 | 357554 |
| Stapley Marc | director, officer: Chief Executive Officer | S-Sale | 19244 | 35.56 | 6.3 2026 | 383833 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 13941 | 36.33 | 6.3 2026 | 131196 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 4400 | 35.55 | 6.3 2026 | 145137 |
| Stapley Marc | director, officer: Chief Executive Officer | F-InKind | 19455 | 36.01 | 4.3 2026 | 403077 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | S-Sale | 13425 | 36.16 | 4.3 2026 | 117346 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | F-InKind | 6035 | 36.01 | 4.3 2026 | 130771 |
| Leite John | officer: Chief Commercial Officer-CLIA | F-InKind | 7517 | 36.01 | 4.3 2026 | 112840 |
| Chambers Rebecca | officer: Chief Financial Officer | F-InKind | 7234 | 36.01 | 4.3 2026 | 149537 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | F-InKind | 3006 | 36.01 | 4.3 2026 | 34909 |
| McGuire Annie | officer: SVP, General Counsel | F-InKind | 6902 | 36.01 | 4.3 2026 | 101364 |
| McGuire Annie | officer: SVP, General Counsel | F-InKind | 10867 | 38.75 | 2.3 2026 | 108266 |
| McGuire Annie | officer: SVP, General Counsel | A-Award | 50999 | 0.00 | 2.3 2026 | 119133 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | F-InKind | 24486 | 38.75 | 2.3 2026 | 136806 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | A-Award | 71806 | 0.00 | 2.3 2026 | 161292 |
| Chambers Rebecca | officer: Chief Financial Officer | F-InKind | 12049 | 38.75 | 2.3 2026 | 156771 |
| Chambers Rebecca | officer: Chief Financial Officer | A-Award | 59324 | 0.00 | 2.3 2026 | 168820 |
| Stapley Marc | director, officer: Chief Executive Officer | F-InKind | 35841 | 38.75 | 2.3 2026 | 422532 |
| Stapley Marc | director, officer: Chief Executive Officer | A-Award | 139074 | 0.00 | 2.3 2026 | 458373 |
| Leite John | officer: Chief Commercial Officer-CLIA | F-InKind | 8905 | 38.75 | 2.3 2026 | 120357 |
| Leite John | officer: Chief Commercial Officer-CLIA | A-Award | 47149 | 0.00 | 2.3 2026 | 129262 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 100 | 43.68 | 17.12 2025 | 67760 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 10639 | 43.13 | 17.12 2025 | 67860 |
| EASTHAM KARIN | director | M-Exempt | 10000 | 7.60 | 8.12 2025 | 0 |
| EASTHAM KARIN | director | M-Exempt | 10000 | 7.94 | 8.12 2025 | 0 |
| EASTHAM KARIN | director | S-Sale | 800 | 46.59 | 8.12 2025 | 13554 |
| EASTHAM KARIN | director | S-Sale | 12808 | 45.84 | 8.12 2025 | 14354 |
| EASTHAM KARIN | director | M-Exempt | 10000 | 7.94 | 8.12 2025 | 23554 |
| EASTHAM KARIN | director | S-Sale | 6392 | 44.52 | 8.12 2025 | 27162 |
| EASTHAM KARIN | director | M-Exempt | 10000 | 7.60 | 8.12 2025 | 33554 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | F-InKind | 1325 | 46.16 | 4.12 2025 | 37420 |
| Leite John | officer: Chief Commercial Officer-CLIA | S-Sale | 1278 | 47.51 | 4.12 2025 | 82113 |
| Leite John | officer: Chief Commercial Officer-CLIA | F-InKind | 2900 | 46.16 | 4.12 2025 | 83391 |
| Stapley Marc | director, officer: Chief Executive Officer | S-Sale | 3220 | 47.35 | 4.12 2025 | 318603 |
| Stapley Marc | director, officer: Chief Executive Officer | S-Sale | 4448 | 46.90 | 4.12 2025 | 321823 |
| Stapley Marc | director, officer: Chief Executive Officer | F-InKind | 7914 | 46.16 | 4.12 2025 | 326271 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 4741 | 47.25 | 4.12 2025 | 109496 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 8537 | 46.61 | 4.12 2025 | 114237 |
| Chambers Rebecca | officer: Chief Financial Officer | F-InKind | 3384 | 46.16 | 4.12 2025 | 122774 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 702 | 47.51 | 4.12 2025 | 78499 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 720 | 47.10 | 4.12 2025 | 79201 |
| McGuire Annie | officer: SVP, General Counsel | F-InKind | 3052 | 46.16 | 4.12 2025 | 79921 |
| Febbo Phillip G. | officer: Chief Scientific & Med Officer | F-InKind | 2955 | 46.16 | 4.12 2025 | 89486 |
| JONES EVAN/ FA | director | S-Sale | 1106 | 50.25 | 26.11 2025 | 29362 |
| Leite John | officer: Chief Commercial Officer-CLIA | S-Sale | 2808 | 50.00 | 26.11 2025 | 86291 |
| Holstein Jens | director | S-Sale | 1460 | 43.21 | 21.11 2025 | 27199 |
| Holstein Jens | director | S-Sale | 7049 | 42.48 | 21.11 2025 | 28659 |
| Holstein Jens | director | S-Sale | 1491 | 40.95 | 21.11 2025 | 35708 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | S-Sale | 5102 | 42.33 | 12.11 2025 | 38745 |
| Wygant Jonathan | officer: VP, Chief Accounting Officer | S-Sale | 5818 | 40.21 | 12.11 2025 | 43847 |
| Chambers Rebecca | officer: Chief Financial Officer | S-Sale | 7000 | 41.00 | 7.11 2025 | 126158 |
| EASTHAM KARIN | director | S-Sale | 9674 | 40.02 | 7.11 2025 | 13554 |
| JONES EVAN/ FA | director | M-Exempt | 10000 | 7.60 | 7.11 2025 | 0 |
| JONES EVAN/ FA | director | M-Exempt | 10000 | 7.94 | 7.11 2025 | 0 |
| JONES EVAN/ FA | director | M-Exempt | 10000 | 5.28 | 7.11 2025 | 0 |
| JONES EVAN/ FA | director | S-Sale | 657 | 46.38 | 7.11 2025 | 30468 |
| JONES EVAN/ FA | director | S-Sale | 24296 | 45.73 | 7.11 2025 | 31125 |
| JONES EVAN/ FA | director | M-Exempt | 10000 | 5.28 | 7.11 2025 | 53664 |
| JONES EVAN/ FA | director | S-Sale | 5872 | 45.07 | 7.11 2025 | 55421 |
| JONES EVAN/ FA | director | S-Sale | 10837 | 43.80 | 7.11 2025 | 61293 |
| JONES EVAN/ FA | director | M-Exempt | 10000 | 7.94 | 7.11 2025 | 63664 |
| JONES EVAN/ FA | director | S-Sale | 1126 | 43.03 | 7.11 2025 | 72130 |
| JONES EVAN/ FA | director | S-Sale | 408 | 41.74 | 7.11 2025 | 73256 |
| JONES EVAN/ FA | director | M-Exempt | 10000 | 7.60 | 7.11 2025 | 73664 |
| McGuire Annie | officer: SVP, General Counsel | S-Sale | 6466 | 40.00 | 7.11 2025 | 82973 |
